SCHEMBL8809654

SCHEMBL8809654

O=c1ccc(-c2c(-c3ccccc3)nn3ccccc23)c[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.51
ADORA1 P30542 2/20 0.50
MAPK14 Q16539 2/20 0.50
IGF1R P08069 2/20 0.50
EGFR P00533 2/20 0.50
RAF1 P04049 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
ADORA2A P29274 1/20 0.50
ADORA2B P29275 1/20 0.50
GSK3B P49841 1/20 0.50
MAPK1 P28482 5/20 0.44
MAPK3 P27361 1/20 0.44
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PDE3A Q14432 3/20 0.41
PDE5A O76074 1/20 0.41
PDE4B Q07343 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5670985 0.85 ADORA2A (0.41) AKT1ADORA1MAPK14IGF1REGFR
SCHEMBL8807929 0.82 IGF1R (0.48) AKT1ADORA1MAPK14IGF1REGFR
SCHEMBL14502354 0.81 AKT1 (0.65) AKT1ADORA1MAPK14IGF1REGFR
SCHEMBL8811997 0.80 IGF1R (0.55) AKT1ADORA1MAPK14IGF1REGFR
SCHEMBL8812720 0.78 AKT1 (0.50) AKT1ADORA1MAPK14IGF1REGFR
SCHEMBL8807356 0.78 IGF1R (0.50) AKT1ADORA1MAPK14IGF1REGFR
SCHEMBL5810385 0.77 PDE3A (0.65) AKT1ADORA1MAPK14IGF1REGFR
SCHEMBL8811408 0.77 MCL1 (0.56) AKT1ADORA1MAPK14IGF1REGFR
SCHEMBL14502340 0.76 AKT1 (0.60) AKT1ADORA1MAPK14IGF1REGFR
SCHEMBL8810466 0.74 MAPK14 (0.78) AKT1ADORA1MAPK14IGF1REGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0379979-B1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1997-03-19 EP disclosed
US-5155114-A Treating or preventing renal toxicity, nephrosis, nephritis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-10-13 US disclosed
US-4985444-A Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-01-15 US disclosed
EP-0379979-A1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-01 EP disclosed